Matrixx is a leading producer of over-the-counter cold remedy and allergy products marketed under the Zicam brand. Matrixx has a history of developing innovative products with unique delivery systems. The Company has a broad distribution platform with a presence in drug, food, mass retailers and warehouse clubs across the U.S. Zicam is currently one of the leading brands in the cold/cough market, having grown significantly over the past decade.

Matrixx should benefit from the strong product pipeline currently in development. The Zicam brand has a significant share of the $ 4.5 billion cold/cough market and we plan to pursue several attractive growth opportunities in the coming years.” – Fraser Preston HIG